EP Biocomposites Limited has announced receiving a substantial work order valued at ₹2.15 crores from Goa Tourism Development Corporation Ltd. The order encompasses the manufacture, supply, transportation, and installation of 1,000 units of Model IV Premium Cast Iron Benches across various designated locations in Goa.

Order Details and Specifications

The comprehensive order details reveal the scope and scale of this infrastructure enhancement project:

The benches are designed to enhance public seating infrastructure, improve visitor convenience, and provide durable, long-term amenities at tourism and public locations throughout the State of Goa.

Related Party Transaction Details

The company has disclosed that this order constitutes a related party transaction. M/s Om Ventures, the entity awarding the order, has a connection to EP Biocomposites Limited through Mrs. Leena Kamat, who serves as a Director of the company and is the sole proprietor of Om Ventures.

Regulatory Compliance and Disclosure

EP Biocomposites Limited has made this disclosure in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company referenced SEBI Circular SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, in its announcement to BSE Limited.

The company emphasized that while this project award falls within the ordinary course of business, the disclosure aligns with good corporate governance practices and their Policy on Materiality of Events and Information. The management noted their track record of receiving repeat orders and delivering projects in a time-bound fashion.

Project Impact and Infrastructure Enhancement

The installation of these premium cast iron benches represents a significant infrastructure development initiative for Goa's tourism sector. The project aims to:

• Enhance public seating infrastructure across the state
• Improve convenience for tourists and visitors
• Provide durable, long-term amenities at key locations
• Support Goa's tourism development objectives

The domestic nature of this contract and its substantial value of ₹2.15 crores demonstrates EP Biocomposites Limited's capability in handling large-scale infrastructure projects for government and tourism development entities.

Source:

EP Biocomposites Limited , a company listed on the BSE SME platform, has reported a significant drop in revenue for the half-year ended September 30, 2025. The company's financial results, approved by its Board of Directors on November 3, 2025, reveal substantial changes in key financial metrics compared to the same period last year.

Revenue and Profitability

The company's revenue from operations saw a steep decline of 46.4%, falling to Rs 407.48 lakhs from Rs 760.13 lakhs in the corresponding period of the previous year. This sharp decrease in revenue had a cascading effect on the company's profitability.

The net profit for the half-year stood at Rs 9.04 lakhs, a sharp 89% decrease from Rs 82.53 lakhs reported in the same period last year. Consequently, the basic earnings per share (EPS) dropped to Rs 0.54 from Rs 4.91.

Operational Performance

Despite the revenue decline, EP Biocomposites managed to control its expenses. The total expenses for the half-year were Rs 402.64 lakhs, down from Rs 655.72 lakhs in the previous year. However, this reduction in expenses was not sufficient to offset the impact of the revenue decline on the company's bottom line.

Balance Sheet Highlights

The company's balance sheet as of September 30, 2025, shows some notable changes:

• Cash and cash equivalents decreased to Rs 87.83 lakhs from Rs 161.67 lakhs at the end of the previous financial year.
• Short-term borrowings increased to Rs 154.36 lakhs from Rs 52.60 lakhs.
• Trade receivables saw a slight decrease to Rs 975.20 lakhs from Rs 1,085.68 lakhs.

Auditor's Review

S.P. Bhandare & Associates, the company's statutory auditors, have conducted a limited review of the financial statements. Their report states that nothing has come to their attention that causes them to believe that the financial results do not present a true and fair view in accordance with applicable accounting standards and generally accepted accounting principles.

EP Biocomposites Limited, operating without any subsidiary, associate, or joint venture companies, faces challenges that have led to this substantial decline in revenue and profitability.